Pricing overhaul

Dispensing fees, pricing discretion and pharmacy layout in the King Review firing line Pharmacies should have no discretion to either raise or lower prices for PBS-listed medicines beyond the co-payment set by the government or the dispensed price, the Review of Pharmacy Remuneration and Regulation has recommended. The interim report of the Review of Pharmacy